About Exosect

Exosect is a lean formulations company. 

We exploit the characteristics of our unique, proprietary technology platforms and apply our extensive formulations know-how to enable the efficient, targeted delivery of biological and synthetic active ingredients. 

Our technology platforms deliver a unique mix of commercial and environmental benefits and are underpinned by an extensive and robust patent portfolio.

We out-license access to our technology platforms, formulations
know-how and intellectual property to industrial partners enabling them to grow their business and increase ROI.

Meet our team

Read about the management team below, or scroll down to see our Board of Directors.

Andrew MacNaughton Chief Executive Officer

Andrew has over 20 years’ experience of a range of international blue chip companies.

Read more...

Andy brings with him more than twenty years’ experience within a range of international blue chip companies in the IT Services, Telecoms, Manufacturing and Defence sectors. His previous roles include Chief Executive Officer MLS at Berwin Leighton Paisner, Executive Director at EADS – Airbus Group, Chairman at TDS Informationstechnologie and Divisional Chief Executive at Fujitsu services.

Andrew MacNaughton - Chief Executive Officer

Jane Terry International Business Development Manager

Jane has over 20 years experience in strategy development working internationally within a wide range of industries.

Read more...

Jane's experience includes sales and brand development for automotive and FMCG grocery industries. She has worked for companies including Saatchi & Saatchi and Leo Burnett.

Jane is responsible for out-licensing strategy development and implementation including across all retail products.

Jane Terry - International Business Development Manager at Exosect

Dr Igor Curcic Head of Formulation Development

Igor joined us in September 2013 and brings with him a broad experience in agrochemicals AI and formulation research and development.

Read more...

He is an expert in analytical instrumentation, method development and physical properties measurements. His background includes experimental design, catalysts synthesis, testing and characterization, chemical kinetics, high pressure reactors, separation techniques and nanoparticles.

Prior to joining Exosect Igor worked at Syngenta.

Igor Curcic - Head of Formulation Development at Exosect

Dr Aoife Dillon Chief Technology Officer

Aoife has over fifteen-years of experience in bio-insecticide development and delivery of IPM strategies.

Read more...

She gained her PhD in Integrated Pest Management at the National University of Ireland. Prior to joining Exosect, Aoife was Technical Specialist for Bio-Insecticides at BASF.

Aoife leads the Technology Development team where she oversees all the development programmes for Exosect’s licensing partners.

Dr Aoife Dillon - Chief Technology Officer

Philip Harris MBA, BSc (Hons), CIPD Chief Administration Officer

Philip is one of the founding members of Exosect having come from the spin-out formation company Southampton Innovations.

Read more...

He is experienced in several technology related start-up companies with whom his responsibilities have included business planning, formation of management teams, raising equity finance along with critical back office functions (HR, QMS, H&S, ICT) and is Company Secretary.

Philip attained an MBA with distinction in 1997 from Imperial College of Science and Technology.

Philip Harris - Chief Administration Officer

Tony Ray Quality Control & Quality Assurance Manager

Tony has 30 years experience of quality control and analysis within the drinks industry

Read more...

Of Tony's 30 years experience within the drinks industry, 4 years was in R&D. He joined Exosect from Bacardi Martini where he was senior analyst.

Tony brings extensive experience in quality control and audit systems plus method development and problem solving within a production environment.

Tony Ray - Quality Control & Quality Assurance Manager at Exosect

The Board

Dr Rob Wylie Chairman

Dr Rob Wylie is the co-founder and Chairman of WHEB, a sustainability focused multi-asset class investment firm and has focused on impact investment for over 25 years.

Read more...

A chemist with an MA and PhD from the University of Cambridge, Rob spent ten years in Shell’s agrochemical business before working in the 1980s with Rothschild’s Bioscience unit investigating environmental investment opportunities. He then joined KPMG where he worked on numerous M&A and privatisation transactions as well as on the development of environmental funds in Central and Eastern Europe.

Rob has been an active participant on numerous industry, UK government and university advisory boards.

Rob Wylie - Co-founder and Chairman of WHEB

Edward Mott – Managing Partner Oxford Capital Partners

Edward co-founded Oxford Capital in 1999 with the intent of broadening the access to private equity to wealthy families and corporations around the world as well as to institutional investors.

Read more...

Ted founded and is Chairman & Joint-Chief Executive of Oxford Capital Partners LLP, an international private equity and venture capital group. After an early career in the USA in business development with a leading technology group, Corning Inc., Ted pursued a career in international investment banking in New York, Paris, London and Hong Kong working across both developed and emerging markets. Ted is a graduate of Cambridge University (MA Economics) and INSEAD Business School (MBA), and speaks fluent English, French and German. He is an experienced builder of businesses, organizational adviser, strategy consultant, frontier investment manager, capital markets specialist and business leader. He serves on the boards of several companies, public and private, in the fields of advanced technologies and life sciences. He has a keen interest in sustainability and is a promoter of modern governance for businesses large and small.

Edward Mott – Managing Partner, Oxford Capital Partners

Alexander HardtmuthEntrepreneurs Fund

Alex is an Investment Manager at Entrepreneurs Fund, the venture capital member of COFRA Holding, one of the world’s largest groups of family-controlled businesses.

Read more...

Alex looks after several investee companies in the portfolio, either as a Director or a Board Observer. Alex started his career in private equity in 2007 with AnaCap Financial Partners, a London-based fund with focus on the financial services sector. He previously had a career as a management consultant with Arthur Andersen and KPMG. Alex holds an MSc Finance degree from London Business School, and an MSc in Industrial Engineering from ETH Zurich, Switzerland.

Alexander Hardtmuth – Investment Manager – Entrepreneurs Fund

David Ward MTI ventures

Managing Partner & Head of Cleantech and Materials Technology Investing

Read more...

David joined MTI in 1999. His sector specialism is Cleantech & Materials Technology. David has a recognised expertise in Nanotechnology and has been the Chair of Nanotech panel sessions for the European Venture Capital Association and at the International Congress of Nano technology.

David holds an MA in Material Science from Oxford University. 

David Ward - Managing Partner & Head of Cleantech and Materials Technology Investing – MTI ventures

Find out more

Fill in the quick form below and we'll get right back to you.
More to say? Use our full enquiry form.